APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plant Derivative Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Plant Derivative Drug Market Analysis and Forecast 2026-2032

2 January 2026196 pages

Choose your research edition.

Industry ResearchPlant Derivative Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Plant Derivative Drug Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Plant Derivative Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plant Derivative Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Plant Derivative Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Plant Derivative Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Plant Derivative Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plant Derivative Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plant Derivative Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plant Derivative Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Plant Derivative Drug include Yunnan Baiyao, Weleda, Tsumura, Tong Ren Tang, Tasly Holding Group, Taiji, Schwabe, Kwangdong and Jumpcan Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Plant Derivative Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plant Derivative Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Plant Derivative Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plant Derivative Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plant Derivative Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plant Derivative Drug revenue, projected growth trends, production technology, application and end-user industry.

Plant Derivative Drug Segment by Company

Yunnan Baiyao

Weleda

Tsumura

Tong Ren Tang

Tasly Holding Group

Taiji

Schwabe

Kwangdong

Jumpcan Pharmaceutical

Huarun 999

GW Pharmaceuticals

Guangzhou Baiyunshan Pharmaceutical

China TCM

Buchang Pharmaceuticals

Bionorica Se

Plant Derivative Drug Segment by Type

Prescription Drug

OTC

Plant Derivative Drug Segment by Application

Tumor

Cardiovascular

Respiratory System

Other

Plant Derivative Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant Derivative Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plant Derivative Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant Derivative Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Plant Derivative Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Plant Derivative Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plant Derivative Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plant Derivative Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prescription Drug Major Player Table 3. OTC Major Player Table 4. Global Plant Derivative Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Tumor Major Player Table 6. Cardiovascular Major Player Table 7. Respiratory System Major Player Table 8. Other Major Player Table 9. Plant Derivative Drug Industry Trends Table 10. Plant Derivative Drug Industry Drivers Table 11. Plant Derivative Drug Industry Opportunities and Challenges Table 12. Plant Derivative Drug Industry Restraints Table 13. Global Plant Derivative Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Plant Derivative Drug Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Plant Derivative Drug Market Share by Region (2021-2026) Table 16. Global Plant Derivative Drug Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Plant Derivative Drug Market Share by Region (2027-2032) Table 18. Global Plant Derivative Drug Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Plant Derivative Drug Revenue Market Share by Players (2021-2026) Table 20. Global Plant Derivative Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Plant Derivative Drug Key Players Headquarters & Area Served Table 22. Global Plant Derivative Drug Players, Product Type & Application Table 23. Global Plant Derivative Drug Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Plant Derivative Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Plant Derivative Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Plant Derivative Drug Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Plant Derivative Drug Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Plant Derivative Drug Revenue Market Share by Type (2021-2026) Table 30. Global Plant Derivative Drug Revenue Market Share by Type (2027-2032) Table 31. Global Plant Derivative Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Plant Derivative Drug Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Plant Derivative Drug Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Plant Derivative Drug Revenue Market Share by Application (2021-2026) Table 35. Global Plant Derivative Drug Revenue Market Share by Application (2027-2032) Table 36. Yunnan Baiyao Company Information Table 37. Yunnan Baiyao Business Overview Table 38. Yunnan Baiyao Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Yunnan Baiyao Plant Derivative Drug Product Portfolio Table 40. Yunnan Baiyao Recent Development Table 41. Weleda Company Information Table 42. Weleda Business Overview Table 43. Weleda Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Weleda Plant Derivative Drug Product Portfolio Table 45. Weleda Recent Development Table 46. Tsumura Company Information Table 47. Tsumura Business Overview Table 48. Tsumura Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Tsumura Plant Derivative Drug Product Portfolio Table 50. Tsumura Recent Development Table 51. Tong Ren Tang Company Information Table 52. Tong Ren Tang Business Overview Table 53. Tong Ren Tang Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Tong Ren Tang Plant Derivative Drug Product Portfolio Table 55. Tong Ren Tang Recent Development Table 56. Tasly Holding Group Company Information Table 57. Tasly Holding Group Business Overview Table 58. Tasly Holding Group Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Tasly Holding Group Plant Derivative Drug Product Portfolio Table 60. Tasly Holding Group Recent Development Table 61. Taiji Company Information Table 62. Taiji Business Overview Table 63. Taiji Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Taiji Plant Derivative Drug Product Portfolio Table 65. Taiji Recent Development Table 66. Schwabe Company Information Table 67. Schwabe Business Overview Table 68. Schwabe Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Schwabe Plant Derivative Drug Product Portfolio Table 70. Schwabe Recent Development Table 71. Kwangdong Company Information Table 72. Kwangdong Business Overview Table 73. Kwangdong Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Kwangdong Plant Derivative Drug Product Portfolio Table 75. Kwangdong Recent Development Table 76. Jumpcan Pharmaceutical Company Information Table 77. Jumpcan Pharmaceutical Business Overview Table 78. Jumpcan Pharmaceutical Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Jumpcan Pharmaceutical Plant Derivative Drug Product Portfolio Table 80. Jumpcan Pharmaceutical Recent Development Table 81. Huarun 999 Company Information Table 82. Huarun 999 Business Overview Table 83. Huarun 999 Plant Derivative Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Huarun 999 Plant Derivative Drug Product Portfolio Table 85. Huarun 999 Recent Development Table 86. GW Pharmaceuticals Company Information Table 87. GW Pharmaceuticals Business Overview Table 88. GW Pharmaceuticals Plant Derivative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. GW Pharmaceuticals Plant Derivative Drug Product Portfolio Table 90. GW Pharmaceuticals Recent Development Table 91. Guangzhou Baiyunshan Pharmaceutical Company Information Table 92. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 93. Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Product Portfolio Table 95. Guangzhou Baiyunshan Pharmaceutical Recent Development Table 96. China TCM Company Information Table 97. China TCM Business Overview Table 98. China TCM Plant Derivative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. China TCM Plant Derivative Drug Product Portfolio Table 100. China TCM Recent Development Table 101. Buchang Pharmaceuticals Company Information Table 102. Buchang Pharmaceuticals Business Overview Table 103. Buchang Pharmaceuticals Plant Derivative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Buchang Pharmaceuticals Plant Derivative Drug Product Portfolio Table 105. Buchang Pharmaceuticals Recent Development Table 106. Bionorica Se Company Information Table 107. Bionorica Se Business Overview Table 108. Bionorica Se Plant Derivative Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Bionorica Se Plant Derivative Drug Product Portfolio Table 110. Bionorica Se Recent Development Table 111. North America Plant Derivative Drug Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Plant Derivative Drug Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Plant Derivative Drug Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Plant Derivative Drug Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Plant Derivative Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Plant Derivative Drug Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Plant Derivative Drug Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Plant Derivative Drug Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Plant Derivative Drug Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Plant Derivative Drug Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Plant Derivative Drug Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Plant Derivative Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Plant Derivative Drug Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Plant Derivative Drug Revenue by Country (US$ Million) & (2027-2032) Table 125. China Plant Derivative Drug Revenue by Type (2021-2026) & (US$ Million) Table 126. China Plant Derivative Drug Revenue by Type (2027-2032) & (US$ Million) Table 127. China Plant Derivative Drug Revenue by Application (2021-2026) & (US$ Million) Table 128. China Plant Derivative Drug Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Plant Derivative Drug Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Plant Derivative Drug Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Plant Derivative Drug Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Plant Derivative Drug Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Plant Derivative Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Plant Derivative Drug Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Plant Derivative Drug Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Plant Derivative Drug Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Plant Derivative Drug Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Plant Derivative Drug Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Plant Derivative Drug Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Plant Derivative Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Plant Derivative Drug Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Plant Derivative Drug Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Plant Derivative Drug Image Figure 2. Global Plant Derivative Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plant Derivative Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prescription Drug Image Figure 5. OTC Image Figure 6. Global Plant Derivative Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Plant Derivative Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Tumor Image Figure 9. Cardiovascular Image Figure 10. Respiratory System Image Figure 11. Other Image Figure 12. Global Plant Derivative Drug Market Size (US$ Million) & (2021-2032) Figure 13. Global Plant Derivative Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Plant Derivative Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Plant Derivative Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Plant Derivative Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Plant Derivative Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Plant Derivative Drug Revenue Market Share by Type (2021-2032) Figure 20. Global Plant Derivative Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Plant Derivative Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Plant Derivative Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Plant Derivative Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Plant Derivative Drug Revenue Share by Type (2021-2032) Figure 25. North America Plant Derivative Drug Revenue Share by Application (2021-2032) Figure 26. North America Plant Derivative Drug Revenue Share by Country (2021-2032) Figure 27. United States Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Plant Derivative Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Plant Derivative Drug Revenue Share by Type (2021-2032) Figure 32. Europe Plant Derivative Drug Revenue Share by Application (2021-2032) Figure 33. Europe Plant Derivative Drug Revenue Share by Country (2021-2032) Figure 34. Germany Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Plant Derivative Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Plant Derivative Drug Revenue Share by Type (2021-2032) Figure 44. China Plant Derivative Drug Revenue Share by Application (2021-2032) Figure 45. Asia Plant Derivative Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Plant Derivative Drug Revenue Share by Type (2021-2032) Figure 47. Asia Plant Derivative Drug Revenue Share by Application (2021-2032) Figure 48. Asia Plant Derivative Drug Revenue Share by Region (2021-2032) Figure 49. Japan Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Plant Derivative Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Plant Derivative Drug Revenue Share by Type (2021-2032) Figure 57. SAMEA Plant Derivative Drug Revenue Share by Application (2021-2032) Figure 58. SAMEA Plant Derivative Drug Revenue Share by Country (2021-2032) Figure 59. Brazil Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Plant Derivative Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drug
  • OTC
Applications
  • Tumor
  • Cardiovascular
  • Respiratory System
  • Other
Companies covered
  • Yunnan Baiyao
  • Weleda
  • Tsumura
  • Tong Ren Tang
  • Tasly Holding Group
  • Taiji
  • Schwabe
  • Kwangdong
  • Jumpcan Pharmaceutical
  • Huarun 999
  • GW Pharmaceuticals
  • Guangzhou Baiyunshan Pharmaceutical
  • China TCM
  • Buchang Pharmaceuticals
  • Bionorica Se

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plant Derivative Drug Market by Type
  3. 1.2.1 Global Plant Derivative Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prescription Drug
  5. 1.2.3 OTC
  6. 1.3 Plant Derivative Drug Market by Application
  7. 1.3.1 Global Plant Derivative Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Tumor
  9. 1.3.3 Cardiovascular
  10. 1.3.4 Respiratory System
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Plant Derivative Drug Market Dynamics
  1. 2.1 Plant Derivative Drug Industry Trends
  2. 2.2 Plant Derivative Drug Industry Drivers
  3. 2.3 Plant Derivative Drug Industry Opportunities and Challenges
  4. 2.4 Plant Derivative Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Plant Derivative Drug Market Perspective (2021-2032)
  2. 3.2 Global Plant Derivative Drug Growth Trends by Region
  3. 3.2.1 Global Plant Derivative Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plant Derivative Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Plant Derivative Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Plant Derivative Drug Revenue by Players
  2. 4.1.1 Global Plant Derivative Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Plant Derivative Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Plant Derivative Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plant Derivative Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Plant Derivative Drug Key Players Headquarters & Area Served
  7. 4.4 Global Plant Derivative Drug Players, Product Type & Application
  8. 4.5 Global Plant Derivative Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Plant Derivative Drug Market CR5 and HHI
  11. 4.6.3 2025 Plant Derivative Drug Tier 1, Tier 2, and Tier 3
5 Plant Derivative Drug Market Size by Type
  1. 5.1 Global Plant Derivative Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Plant Derivative Drug Revenue by Type (2021-2032)
  3. 5.3 Global Plant Derivative Drug Revenue Market Share by Type (2021-2032)
6 Plant Derivative Drug Market Size by Application
  1. 6.1 Global Plant Derivative Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Plant Derivative Drug Revenue by Application (2021-2032)
  3. 6.3 Global Plant Derivative Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Yunnan Baiyao
  2. 7.1.1 Yunnan Baiyao Company Information
  3. 7.1.2 Yunnan Baiyao Business Overview
  4. 7.1.3 Yunnan Baiyao Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Yunnan Baiyao Plant Derivative Drug Product Portfolio
  6. 7.1.5 Yunnan Baiyao Recent Developments
  7. 7.2 Weleda
  8. 7.2.1 Weleda Company Information
  9. 7.2.2 Weleda Business Overview
  10. 7.2.3 Weleda Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Weleda Plant Derivative Drug Product Portfolio
  12. 7.2.5 Weleda Recent Developments
  13. 7.3 Tsumura
  14. 7.3.1 Tsumura Company Information
  15. 7.3.2 Tsumura Business Overview
  16. 7.3.3 Tsumura Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Tsumura Plant Derivative Drug Product Portfolio
  18. 7.3.5 Tsumura Recent Developments
  19. 7.4 Tong Ren Tang
  20. 7.4.1 Tong Ren Tang Company Information
  21. 7.4.2 Tong Ren Tang Business Overview
  22. 7.4.3 Tong Ren Tang Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Tong Ren Tang Plant Derivative Drug Product Portfolio
  24. 7.4.5 Tong Ren Tang Recent Developments
  25. 7.5 Tasly Holding Group
  26. 7.5.1 Tasly Holding Group Company Information
  27. 7.5.2 Tasly Holding Group Business Overview
  28. 7.5.3 Tasly Holding Group Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Tasly Holding Group Plant Derivative Drug Product Portfolio
  30. 7.5.5 Tasly Holding Group Recent Developments
  31. 7.6 Taiji
  32. 7.6.1 Taiji Company Information
  33. 7.6.2 Taiji Business Overview
  34. 7.6.3 Taiji Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Taiji Plant Derivative Drug Product Portfolio
  36. 7.6.5 Taiji Recent Developments
  37. 7.7 Schwabe
  38. 7.7.1 Schwabe Company Information
  39. 7.7.2 Schwabe Business Overview
  40. 7.7.3 Schwabe Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Schwabe Plant Derivative Drug Product Portfolio
  42. 7.7.5 Schwabe Recent Developments
  43. 7.8 Kwangdong
  44. 7.8.1 Kwangdong Company Information
  45. 7.8.2 Kwangdong Business Overview
  46. 7.8.3 Kwangdong Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Kwangdong Plant Derivative Drug Product Portfolio
  48. 7.8.5 Kwangdong Recent Developments
  49. 7.9 Jumpcan Pharmaceutical
  50. 7.9.1 Jumpcan Pharmaceutical Company Information
  51. 7.9.2 Jumpcan Pharmaceutical Business Overview
  52. 7.9.3 Jumpcan Pharmaceutical Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Jumpcan Pharmaceutical Plant Derivative Drug Product Portfolio
  54. 7.9.5 Jumpcan Pharmaceutical Recent Developments
  55. 7.10 Huarun 999
  56. 7.10.1 Huarun 999 Company Information
  57. 7.10.2 Huarun 999 Business Overview
  58. 7.10.3 Huarun 999 Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Huarun 999 Plant Derivative Drug Product Portfolio
  60. 7.10.5 Huarun 999 Recent Developments
  61. 7.11 GW Pharmaceuticals
  62. 7.11.1 GW Pharmaceuticals Company Information
  63. 7.11.2 GW Pharmaceuticals Business Overview
  64. 7.11.3 GW Pharmaceuticals Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 GW Pharmaceuticals Plant Derivative Drug Product Portfolio
  66. 7.11.5 GW Pharmaceuticals Recent Developments
  67. 7.12 Guangzhou Baiyunshan Pharmaceutical
  68. 7.12.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  69. 7.12.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  70. 7.12.3 Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Product Portfolio
  72. 7.12.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  73. 7.13 China TCM
  74. 7.13.1 China TCM Company Information
  75. 7.13.2 China TCM Business Overview
  76. 7.13.3 China TCM Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 China TCM Plant Derivative Drug Product Portfolio
  78. 7.13.5 China TCM Recent Developments
  79. 7.14 Buchang Pharmaceuticals
  80. 7.14.1 Buchang Pharmaceuticals Company Information
  81. 7.14.2 Buchang Pharmaceuticals Business Overview
  82. 7.14.3 Buchang Pharmaceuticals Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Buchang Pharmaceuticals Plant Derivative Drug Product Portfolio
  84. 7.14.5 Buchang Pharmaceuticals Recent Developments
  85. 7.15 Bionorica Se
  86. 7.15.1 Bionorica Se Company Information
  87. 7.15.2 Bionorica Se Business Overview
  88. 7.15.3 Bionorica Se Plant Derivative Drug Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Bionorica Se Plant Derivative Drug Product Portfolio
  90. 7.15.5 Bionorica Se Recent Developments
8 North America
  1. 8.1 North America Plant Derivative Drug Revenue (2021-2032)
  2. 8.2 North America Plant Derivative Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Plant Derivative Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Plant Derivative Drug Revenue by Type (2027-2032)
  5. 8.3 North America Plant Derivative Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Plant Derivative Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Plant Derivative Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Plant Derivative Drug Revenue by Application (2027-2032)
  9. 8.5 North America Plant Derivative Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Plant Derivative Drug Revenue by Country
  11. 8.6.1 North America Plant Derivative Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Plant Derivative Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Plant Derivative Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Plant Derivative Drug Revenue (2021-2032)
  2. 9.2 Europe Plant Derivative Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Plant Derivative Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Plant Derivative Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Plant Derivative Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Plant Derivative Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Plant Derivative Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Plant Derivative Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Plant Derivative Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Plant Derivative Drug Revenue by Country
  11. 9.6.1 Europe Plant Derivative Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Plant Derivative Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Plant Derivative Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Plant Derivative Drug Revenue (2021-2032)
  2. 10.2 China Plant Derivative Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Plant Derivative Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Plant Derivative Drug Revenue by Type (2027-2032)
  5. 10.3 China Plant Derivative Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Plant Derivative Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Plant Derivative Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Plant Derivative Drug Revenue by Application (2027-2032)
  9. 10.5 China Plant Derivative Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plant Derivative Drug Revenue (2021-2032)
  2. 11.2 Asia Plant Derivative Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Plant Derivative Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Plant Derivative Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Plant Derivative Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Plant Derivative Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Plant Derivative Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Plant Derivative Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Plant Derivative Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Plant Derivative Drug Revenue by Country
  11. 11.6.1 Asia Plant Derivative Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Plant Derivative Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Plant Derivative Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plant Derivative Drug Revenue (2021-2032)
  2. 12.2 SAMEA Plant Derivative Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Plant Derivative Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Plant Derivative Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Plant Derivative Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Plant Derivative Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Plant Derivative Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Plant Derivative Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Plant Derivative Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Plant Derivative Drug Revenue by Country
  11. 12.6.1 SAMEA Plant Derivative Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Plant Derivative Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Plant Derivative Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst